Efficacy of Changing to TRAVATAN® From Prior Therapy
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the efficacy and tolerability of TRAVATAN® Solution
without benzalkonium chloride (BAK) in patients previously on latanoprost 0.005% or
bimatoprost 0.01% ophthalmic solution monotherapy.